These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 23880476)

  • 1. Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group.
    Furtwängler R; Gooskens SL; van Tinteren H; de Kraker J; Schleiermacher G; Bergeron C; de Camargo B; Acha T; Godzinski J; Sandstedt B; Leuschner I; Vujanic GM; Pieters R; Graf N; van den Heuvel-Eibrink MM
    Eur J Cancer; 2013 Nov; 49(16):3497-506. PubMed ID: 23880476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5.
    Kalapurakal JA; Perlman EJ; Seibel NL; Ritchey M; Dome JS; Grundy PE
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):428-31. PubMed ID: 22658515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary lung metastases in pediatric malignant non-Wilms renal tumors: data from SIOP 93-01/GPOH and SIOP 2001/GPOH.
    Warmann SW; Nourkami N; Frühwald M; Leuschner I; Schenk JP; Fuchs J; Graf N
    Klin Padiatr; 2012 Apr; 224(3):148-52. PubMed ID: 22513793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.
    Graf N; van Tinteren H; Bergeron C; Pein F; van den Heuvel-Eibrink MM; Sandstedt B; Schenk JP; Godzinski J; Oldenburger F; Furtwängler R; de Kraker J
    Eur J Cancer; 2012 Nov; 48(17):3240-8. PubMed ID: 22795263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear cell sarcoma of the kidney: patients' characteristics and improved outcome in developing countries.
    Zekri W; Alfaar AS; Yehia D; Elshafie MM; Zaghloul MS; El-Kinaai N; Taha H; Refaat A; Younes AA
    Pediatr Blood Cancer; 2014 Dec; 61(12):2185-90. PubMed ID: 25175045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.
    Seibel NL; Li S; Breslow NE; Beckwith JB; Green DM; Haase GM; Ritchey ML; Thomas PR; Grundy PE; Finklestein JZ; Kim T; Shochat SJ; Kelalis PP; D'Angio GJ
    J Clin Oncol; 2004 Feb; 22(3):468-73. PubMed ID: 14752069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study group.
    van den Heuvel-Eibrink MM; van Tinteren H; Rehorst H; Coulombe A; Patte C; de Camargo B; de Kraker J; Leuschner I; Lugtenberg R; Pritchard-Jones K; Sandstedt B; Spreafico F; Graf N; Vujanic GM
    Pediatr Blood Cancer; 2011 May; 56(5):733-7. PubMed ID: 21370404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP study.
    Gooskens SL; Furtwängler R; Spreafico F; van Tinteren H; de Kraker J; Vujanic GM; Leuschner I; Coulomb-L'Herminé A; Godzinski J; Schleiermacher G; Stoneham S; Bergeron C; Pritchard-Jones K; Graf N; van den Heuvel-Eibrink MM
    Br J Cancer; 2014 Jul; 111(2):227-33. PubMed ID: 24937667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2.
    Benedetti DJ; Renfro LA; Tfirn I; Daw NC; Kalapurakal JA; Ehrlich PF; Khanna G; Perlman E; Warwick A; Gow KW; Paulino AC; Seibel NL; Grundy P; Fernandez CV; Geller JI; Mullen EA; Dome JS
    Cancer; 2024 Jul; 130(13):2361-2371. PubMed ID: 38396300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of children with clear cell sarcoma of kidney following NWTS strategies in Shanghai China (2003-2021).
    Zhang A; Yuan X; Jiang S; Xu D; Huang C; Tang JY; Gao Y
    PLoS One; 2024; 19(7):e0306863. PubMed ID: 38980838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clear cell sarcoma: a dilemma on pathological staging and clinical management.
    Ng A; Jenkinson H; Morland B; Grundy R
    Pediatr Hematol Oncol; 2005; 22(3):257-61. PubMed ID: 16020110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001.
    Hol JA; Lopez-Yurda MI; Van Tinteren H; Van Grotel M; Godzinski J; Vujanic G; Oldenburger F; De Camargo B; Ramírez-Villar GL; Bergeron C; Pritchard-Jones K; Graf N; Van den Heuvel-Eibrink MM
    PLoS One; 2019; 14(8):e0221373. PubMed ID: 31425556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study.
    Reinhard H; Aliani S; Ruebe C; Stöckle M; Leuschner I; Graf N
    J Clin Oncol; 2004 Nov; 22(22):4500-6. PubMed ID: 15542800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study.
    Grundy RG; Hutton C; Middleton H; Imeson J; Pritchard J; Kelsey A; Marsden HB; Vujanic GM; Taylor RE;
    Pediatr Blood Cancer; 2004 Apr; 42(4):311-9. PubMed ID: 14966826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical aspects in the treatment of patients with unilateral wilms tumor: a report from the SIOP 93-01/German Society of Pediatric Oncology and Hematology.
    Fuchs J; Kienecker K; Furtwängler R; Warmann SW; Bürger D; Thürhoff JW; Hager J; Graf N
    Ann Surg; 2009 Apr; 249(4):666-71. PubMed ID: 19300220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of recurrent clear cell sarcoma of the kidney with brain metastasis.
    Radulescu VC; Gerrard M; Moertel C; Grundy PE; Mathias L; Feusner J; Diller L; Dome JS
    Pediatr Blood Cancer; 2008 Feb; 50(2):246-9. PubMed ID: 17226850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoblastic nephroma--a report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH).
    Furtwaengler R; Reinhard H; Leuschner I; Schenk JP; Goebel U; Claviez A; Kulozik A; Zoubek A; von Schweinitz D; Graf N;
    Cancer; 2006 May; 106(10):2275-83. PubMed ID: 16596620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clear cell sarcoma of the kidney. A study of 13 cases].
    El Kababri M; Khattab M; El Khorassani M; Hessissen L; Kili A; Nachef MN; Cherradi N; Malihy A; Alhamany Z; Msefer-Alaoui F
    Arch Pediatr; 2004 Jul; 11(7):794-9. PubMed ID: 15234374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.